VanEck Genomics and Healthcare Innovators UCITS ETF (CURE)

Waiting on other stocks to mature?

~STEX $1.23 with 10M share buy-back news....

Streamex Corp. Announces 10,000,000 Share Repurchase Program

https://www.globenewswire.com/news-release/2026/07/07/3323059/22558/en/streamex-corp-announces-10-000-000-share-repurchase-program.html

SUGP...$1.09...🥳...

georgie18

Re: georgie18 post# 97

Tuesday, June 16, 2026 9:00:35 AM

Post#
98
of 101
SUGP...$2.40...🥳...Took 1/2 off the table...

georgie18

Re: georgie1

SUGP...$1.09...🥳...

georgie18

Re: georgie18 post# 97

Tuesday, June 16, 2026 9:00:35 AM

Post#
98
of 101
SUGP...$2.40...🥳...Took 1/2 off the table...

georgie18

Re: georgie1

Looks like TRLV is expanding in TX. https://finance.yahoo.com/healthcare/articles/trulieve-plans-texas-medical-marijuana-204050341.html. Power On.

Nice and thanks! Looking forward to hearing if Delfin has done any further testing on the line and work on the site. Also, to your point, whether Williams has the capacity to feed the FLNG's without the need for a new compression station. Still thinking it's in their best interest to have their own

What is now abundantly clear for me is that one of the foundational fronts Dr. Joel Gagnier spearheads, just one, is focused on a clinical trial control tool that can be widely used across Orthopaedics field, and perhaps many other clinical fields.

This publication was accepted in Jun

Wrong again. RadioGel isn’t some expired public domain idea anyone can just copy tomorrow. It’s protected by patents — and that actually matters. A competitor can’t just reverse-engineer it and flood the market. Even if they tried, they’d still have to run their own full clinical program, get their

North,
https://finance.yahoo.com/markets/stocks/articles/why-eyepoint-inc-eypt-among-055352083.html
August should be the first catalyst for the company. Should create a sugar rush. It won't hold long term
Sleven,

Thi s is the good news we wanted to start the second half

Plug Power Inc. (NASDAQ: PLUG), a global leader in comprehensive hydrogen solutions for the hydrogen economy, today announced that the 50-megawatt (MW) Hunter Valley Hydrogen Hub (HVHH) project in Newcastle, New South Wales, A

$AABB Undervalued ~ AABB’s $212M Assets vs $68 6M Market Cap Bullion Alone Tops Valuation!
https://www.youtube.com/watch?v=H8bCJyOtGbo

https://www.youtube.com/watch?v=H8bCJyOtGbo

Undervalued ~ AABB’s $212M Assets vs $68 6M Market Cap Bullion Alone Tops Valuation!
https://www.youtube.com/watch?v=H8bCJyOtGbo

https://www.youtube.com/watch?v=H8bCJyOtGbo

Yeah, the $5,000,000.00 probably had zero to do with greed, just like the 79 MILLION warrants had nothing to do with greed !!!!!!!!!!!!!!!!!

I know the DollarLand Goal or The Nasdaq Goal hasn't been hit since the current CEO took over in 2013, but I'm just glad he is taking care of hi

Toogood Gold Provides Phase 1 Exploration Update at Table Mountain Gold-Silver Project, NevadaJuly 7, 2026 7:00 AM
NewsfileVancouver, B

Expansion Drilling Commences at Eloro Resources Ltd.'s Iska Iska Project, Southern BoliviaJuly 7, 2026 7:00 AM
Newsfile

Excalibur Metals Appoints Lewis Lawrick to Chairman of the BoardJuly 7, 2026 7:00 AM
NewsfileVancouver, British Columbia--(Newsfile Cor

Lockheed Martin and Rheinmetall partner to manufacture ATACMS missiles in Germany (LMT)July 7, 2026 7:10 AM
IH Market News

DXC Opens Flagship AI-first Customer Experience Center in BengaluruJuly 7, 2026 7:20 AM
PR Newswire (US) Strengthens DXC's India presence with a 200,000-square-foot facility in BengaluruBrings together customer collaboration sp

Looking through Dr. Joel Gagnier search history along with Fifty 1 Labs Inc. Here is one thing we all can take from this is that Dr. Gagnier is the real deal. You can find him all over the internet, symposia, societies, webinars. He specifically is focused on clinical musculoskeletal research and da

Your post aged like milk. You swore the study wasn’t what the FDA asked for and that MK was hiding something with the second set of rabbits. The FDA reviewed the full data package anyway — and approved it. Turns out you were just lying. Again.

Sales and revenue are up 1,000%, yet the stock price isn't moving past $0.0003; what kind of news needs to come out for it to rise further?

Resistance revised down to $15.67.

$6.71 ~Rig

RDGL put in a limited application for 5 patients with nothing to lose. Obviously that should have been done decades ago. Not my fault MK is a gross incompetent who ignored everything FDA suggested.